Matsukura S, Kakita T, Hirata Y, Yoshimi H, Fukase M
J Clin Endocrinol Metab. 1977 Feb;44(2):392-7. doi: 10.1210/jcem-44-2-392.
The adenylate cyclase responses of the human GH or ACTH producing pituitary adenomas and ectopic ACTH producing tumors to TRH, LH-RH, biogenic amines, peptides hormones, PGE1 and rat median eminence extract (MEE) have been examined. Out of 4 GH producing pituitary adenomas obtained from patients with active acromegaly at hypophysectomy two were stimulated by TRH, two by LH-RH, three by norepinephrine, one by dopamine, four by PGE1 and none by serotonin. Glucagon stimulated the adenylate cyclase in one of three and MEE in both of two tested. The positive responses of paradoxical GH release after TRH and/or LH-RH before surgery in these patients coincidentally related to the response of adenylate cyclase of each pituitary adenoma. There seems, however, to be no consistent correlation between the adenylate cyclase responses to biogenic amines and the GH release after L-Dopa or 5-hydroxytroptophan tested. The adenylate cyclase of a pituitary adenoma from case of Cushing's disease was stimulated by LH-RH, norepinephrine glucagon and MEE but not by TRH. Plasma levels of ACTH, beta-MSH and cortisol increased after LH-RH but not after TRH in this patient before hypophysectomy. The adenylate cyclase of two ectopic ACTH producing tumors (gastric carcinoid and malignant thymoma) was activated by TRH, LH-RH, norepinephrine, epinephrine, serotonin, PGE1 and MEE. These results indicate the presence of multiple hormone receptors in GH or ACTH producing pituitary adenomas and ectopic ACTH producing tumors, and suggest that the paradoxical GH or ACTH release after TRH and/or LH-RH injection in acromegaly and Cushing's syndrome might be caused by an alteration of the cellular membrane receptors of the pituitary adenomas.
已对产生人类生长激素(GH)或促肾上腺皮质激素(ACTH)的垂体腺瘤以及产生异位ACTH的肿瘤对促甲状腺激素释放激素(TRH)、促黄体生成素释放激素(LH-RH)、生物胺、肽类激素、前列腺素E1(PGE1)和大鼠正中隆起提取物(MEE)的腺苷酸环化酶反应进行了检测。在垂体切除术中从患有活动性肢端肥大症的患者身上获取的4例产生GH的垂体腺瘤中,2例受TRH刺激,2例受LH-RH刺激,3例受去甲肾上腺素刺激,1例受多巴胺刺激,4例受PGE1刺激,无1例受血清素刺激。胰高血糖素在3例中的1例刺激了腺苷酸环化酶,MEE在2例受试病例中均刺激了腺苷酸环化酶。这些患者术前TRH和/或LH-RH后出现的矛盾性GH释放的阳性反应与每个垂体腺瘤的腺苷酸环化酶反应恰好相关。然而,腺苷酸环化酶对生物胺的反应与左旋多巴或5-羟色氨酸检测后的GH释放之间似乎没有一致的相关性。来自库欣病病例的垂体腺瘤的腺苷酸环化酶受LH-RH、去甲肾上腺素、胰高血糖素和MEE刺激,但不受TRH刺激。该患者垂体切除术前,LH-RH后促肾上腺皮质激素(ACTH)、β-促黑素(β-MSH)和皮质醇的血浆水平升高,但TRH后未升高。2例产生异位ACTH的肿瘤(胃类癌和恶性胸腺瘤)的腺苷酸环化酶受TRH、LH-RH、去甲肾上腺素、肾上腺素、血清素、PGE1和MEE激活。这些结果表明,产生GH或ACTH的垂体腺瘤以及产生异位ACTH的肿瘤中存在多种激素受体,并提示肢端肥大症和库欣综合征患者注射TRH和/或LH-RH后出现的矛盾性GH或ACTH释放可能是由垂体腺瘤细胞膜受体改变所致。